These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24265690)

  • 1. Asymptomatic Clostridium difficile colonisation and onward transmission.
    Eyre DW; Griffiths D; Vaughan A; Golubchik T; Acharya M; O'Connor L; Crook DW; Walker AS; Peto TE
    PLoS One; 2013; 8(11):e78445. PubMed ID: 24265690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
    Riggs MM; Sethi AK; Zabarsky TF; Eckstein EC; Jump RL; Donskey CJ
    Clin Infect Dis; 2007 Oct; 45(8):992-8. PubMed ID: 17879913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.
    Halstead FD; Ravi A; Thomson N; Nuur M; Hughes K; Brailey M; Oppenheim BA
    J Hosp Infect; 2019 Jun; 102(2):125-134. PubMed ID: 30359648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
    Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
    Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Determination of Relative Risks for Clostridioides difficile Infection From Asymptomatic Carriage in Intensive Care Unit Patients.
    Worley J; Delaney ML; Cummins CK; DuBois A; Klompas M; Bry L
    Clin Infect Dis; 2021 Oct; 73(7):e1727-e1736. PubMed ID: 32676661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.
    Nissle K; Kopf D; Rösler A
    BMC Geriatr; 2016 Nov; 16(1):185. PubMed ID: 27846818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic carriage of Clostridium difficile in an Irish continuing care institution for the elderly: prevalence and characteristics.
    Ryan J; Murphy C; Twomey C; Paul Ross R; Rea MC; MacSharry J; Sheil B; Shanahan F
    Ir J Med Sci; 2010 Jun; 179(2):245-50. PubMed ID: 19495833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for asymptomatic Clostridium difficile carriage.
    Alasmari F; Seiler SM; Hink T; Burnham CA; Dubberke ER
    Clin Infect Dis; 2014 Jul; 59(2):216-22. PubMed ID: 24755858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission of Clostridium difficile from asymptomatically colonized or infected long-term care facility residents.
    Donskey CJ; Sunkesula VCK; Stone ND; Gould CV; McDonald LC; Samore M; Mayer J; Pacheco SM; Jencson AL; Sambol SP; Petrella LA; Gulvik CA; Gerding DN
    Infect Control Hosp Epidemiol; 2018 Aug; 39(8):909-916. PubMed ID: 29848392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection.
    Galdys AL; Curry SR; Harrison LH
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):967-80. PubMed ID: 24848084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile rates in asymptomatic and symptomatic hospitalized patients using nucleic acid testing.
    Truong C; Schroeder LF; Gaur R; Anikst VE; Komo I; Watters C; McCalley E; Kulik C; Pickham D; Lee NJ; Banaei N
    Diagn Microbiol Infect Dis; 2017 Apr; 87(4):365-370. PubMed ID: 28087170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
    Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.
    Walker AS; Eyre DW; Wyllie DH; Dingle KE; Harding RM; O'Connor L; Griffiths D; Vaughan A; Finney J; Wilcox MH; Crook DW; Peto TE
    PLoS Med; 2012 Feb; 9(2):e1001172. PubMed ID: 22346738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of clostridium difficile and vancomycin-resistant Enterococcus colonization in patients on a spinal cord injury unit.
    Dumford DM; Nerandzic M; Chang S; Richmond MA; Donskey C
    J Spinal Cord Med; 2011; 34(1):22-7. PubMed ID: 21528623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmissibility of Clostridium difficile Without Contact Isolation: Results From a Prospective Observational Study With 451 Patients.
    Widmer AF; Frei R; Erb S; Stranden A; Kuijper EJ; Knetsch CW; Tschudin-Sutter S
    Clin Infect Dis; 2017 Feb; 64(4):393-400. PubMed ID: 28172613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infection.
    Burke DG; Harrison MJ; Fleming C; McCarthy M; Shortt C; Sulaiman I; Murphy DM; Eustace JA; Shanahan F; Hill C; Stanton C; Rea MC; Ross RP; Plant BJ
    J Cyst Fibros; 2017 Mar; 16(2):291-298. PubMed ID: 27908697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid Detection of Clostridium difficile Toxins in Stool by Raman Spectroscopy.
    Koya SK; Yurgelevic S; Brusatori M; Huang C; Diebel LN; Auner GW
    J Surg Res; 2019 Dec; 244():111-116. PubMed ID: 31279995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea.
    Shim JK; Johnson S; Samore MH; Bliss DZ; Gerding DN
    Lancet; 1998 Feb; 351(9103):633-6. PubMed ID: 9500319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factors.
    Ziakas PD; Zacharioudakis IM; Zervou FN; Grigoras C; Pliakos EE; Mylonakis E
    PLoS One; 2015; 10(2):e0117195. PubMed ID: 25707002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease.
    Meltzer E; Smollan G; Huppert A; Fluss R; Tal I; Gilboa M; Zilberman-Daniels T; Keller N; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2019 Sep; 25(9):1127-1132. PubMed ID: 30771530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.